| 产品名称： | BC-1 |
|---|---|
| 商品货号： | TS212617 |
| Organism： | Homo sapiens, human |
| Cell Type： | B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 CELLS CONTAIN HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | lymphoma |
| Age： | 46 years |
| Gender： | male |
| Applications： | Transfection host. It is also a practical source of KSHV DNA to be used as a positive control for screening tests. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | BC-1 is a lymphoma cell line originated in 1992 by Ethel Cesarman and Giorgio Inghirami in the laboratory of Daniel M. Knowles. The cells were derived from an acquired immunodeficiency syndrome (AIDS) related body cavity based lymphoma presenting as a primary lymphomatous effusion in the peritoneal cavity. |
| Antigen Expression： | CD30 +; CD45 +; EMA + (epithelial membrane antigen) |
| Comments： | The cells contain two viral genomes: Epstein-Barr virus (EBV) and Kaposi sarcoma associated herpesvirus (KSHV, provisionally designed HHV-8). KSHV is a recently identified and largely uncharacterized virus. The BC-1 cell line allows in vitro culture of KSHV viral genomes. |
| Complete Growth Medium： | RPMI 1640 medium, 80%; fetal bovine serum, 20%
|
| Subculturing： | Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 x 105 cells/mL and maintain between 5 x 105 and 2 x 106 cells/mL. Medium Renewal: Every 2 to 3 days |
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| STR Profile： | Amelogenin: X,Y CSF1PO: 10,11 D13S317: 8 D16S539: 12,13 D5S818: 11,12 D7S820: 11 THO1: 9.3 TPOX: 8,9 vWA: 16,20 |
| Population Doubling Time： | 48 to 72 hrs |
| Name of Depositor： | E Cesarman |
| Deposited As： | Homo sapiens |
| References： | Moore PS, et al. Primary characterization of a herpesvirus agent associated with Kaposis sarcoma. J. Virol. 70: 549-558, 1996. PubMed: 8523568 Cesarman E, et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposis sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86: 2708-2714, 1995. PubMed: 7670109 Chadburn A, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72: 3078-3090, 1993. PubMed: 8221575 Cesarman E, et al. Kaposis sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N. Engl. J. Med. 332: 1186-1191, 1995. PubMed: 7700311 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | BC-1 |
|---|---|
| 商品货号： | TS212617 |
| Organism： | Homo sapiens, human |
| Cell Type： | B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 2 CELLS CONTAIN HERPESVIRUS
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | lymphoma |
| Age： | 46 years |
| Gender： | male |
| Applications： | Transfection host. It is also a practical source of KSHV DNA to be used as a positive control for screening tests. |
| Storage Conditions： | liquid nitrogen vapor phase |
| Derivation： | BC-1 is a lymphoma cell line originated in 1992 by Ethel Cesarman and Giorgio Inghirami in the laboratory of Daniel M. Knowles. The cells were derived from an acquired immunodeficiency syndrome (AIDS) related body cavity based lymphoma presenting as a primary lymphomatous effusion in the peritoneal cavity. |
| Antigen Expression： | CD30 +; CD45 +; EMA + (epithelial membrane antigen) |
| Comments： | The cells contain two viral genomes: Epstein-Barr virus (EBV) and Kaposi sarcoma associated herpesvirus (KSHV, provisionally designed HHV-8). KSHV is a recently identified and largely uncharacterized virus. The BC-1 cell line allows in vitro culture of KSHV viral genomes. |
| Complete Growth Medium： | RPMI 1640 medium, 80%; fetal bovine serum, 20%
|
| Subculturing： | Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 5 x 105 cells/mL and maintain between 5 x 105 and 2 x 106 cells/mL. Medium Renewal: Every 2 to 3 days |
| Cryopreservation： | Culture medium, 95%; DMSO, 5% |
| STR Profile： | Amelogenin: X,Y CSF1PO: 10,11 D13S317: 8 D16S539: 12,13 D5S818: 11,12 D7S820: 11 THO1: 9.3 TPOX: 8,9 vWA: 16,20 |
| Population Doubling Time： | 48 to 72 hrs |
| Name of Depositor： | E Cesarman |
| Deposited As： | Homo sapiens |
| References： | Moore PS, et al. Primary characterization of a herpesvirus agent associated with Kaposis sarcoma. J. Virol. 70: 549-558, 1996. PubMed: 8523568 Cesarman E, et al. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposis sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86: 2708-2714, 1995. PubMed: 7670109 Chadburn A, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 72: 3078-3090, 1993. PubMed: 8221575 Cesarman E, et al. Kaposis sarcoma-associated herpesvirus-like DNA sequences in AIDS- related body-cavity-based lymphomas. N. Engl. J. Med. 332: 1186-1191, 1995. PubMed: 7700311 |
